Pfizer and BioNTech said Friday that the US Food and Drug Administration has granted priority review designation to their application for full approval of their Covid-19 vaccine, and an FDA official said the decision will come “soon”.
The FDA official told CNN on Friday that a decision on full approval is likely to come within two months. The agency considers this matter a priority, said the official, who asked not to be named because they were not authorized to speak publicly on the matter.
Full approval could have an impact on vaccine mandates — several schools and business have suggested they would consider mandating Covid-19 vaccines once they are approved. It may also help sway skeptics hesitant to get the vaccines now.
Read the full article.
FDA grants priority review to Pfizer/BioNTech Covid-19 vaccine; agency official says approval decision expected within two monthshttps://t.co/b8EDRbao8W
— Ram Ramgopal (@RamCNN) July 16, 2021